Health & Nutrition
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU...
CEO Paul Chaplin told CNBC that the expanded approval for 12 to 17 year-olds would...
Biden administration releases prices of 10 drugs in Medicare...
It is a milestone in a controversial process that aims to make costly medications...
Healthy Returns: Eli Lilly gains momentum against Novo...
Eli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market....
The 411 on Statins
The cholesterol-lowering statin drug Lipitor has become the best-selling drug of...
Digital health company Ro launches GLP-1 insurance-coverage...
Ro said it hopes its new tool will be able to help patients understand their GLP-1...
Eli Lilly blows past estimates, hikes guidance as Zepbound,...
The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro...
Eating to Lower Lp(a)
What should we eat—and not eat—to lower the cardiovascular disease risk factor lipoprotein(a)?...
Novo Nordisk shares dip as Wegovy maker posts earnings...
Novo Nordisk on Wednesday announced its second quarter earnings for 2024.
Healthy Returns: What drugmakers are saying about final...
Drugmakers appear to be less concerned about the impact of negotiated prices on...
CVS slashes profit guidance, will cut $2 billion in expenses...
CVS said higher medical costs are weighing on its insurance business, and announced...